JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS Vol. 32, no. 2, 195-198 (2018)
Low-grade chronic inflammation mediated by mast cells in fibromyalgia.
F. Mastrangelo 1, I. Frydas 2, G. Ronconi 3, S.K. Kritas 4, L. Tettamanti 5, Al. Caraffa 6, C. D’Ovidio 7, A. Younes 8, C.E. Gallenga 9, P. Conti 10
1 Department of Medical Science and Biotechnology, University of Foggia, Foggia, Italy
2 Faculty of Parasitology, Aristotle University of Thessaloniki, Macedonia, Greece
3 UOS Clinica dei Pazienti del Territorio, Policlinico Gemelli, Rome, Italy
4 Department of Microbiology and Infectious Diseases, Aristotle University of Thessaloniki, Macedonia, Greece
5 Department of Medical and Morphological Science, University of Insubria, Varese, Italy
6 Department of Pharmacology, University of Perugia, Perugia, Italy
7 Section of Legal Medicine, Department of Medicine and Aging Sciences, University of
Chieti-Pescara, Chieti, Italy
8 Department of Anesthesiology, ‘Santo Spirito’ Hospital, Pescara, Italy
9 Department of Biomedical Sciences and Specialist Surgery, Section of Ophthalmology, University of Ferrara, Italy
10 Immunology Division, Postgraduate Medical School, University of Chieti-Pescara, Chieti, Italy
It has been observed that acute stress causes the activation of TH1 cells, while TH2 cells regulate and act on chronic inflammation. Fibromyalgia (FM) is a chronic, idiopathic disorder which affects about twelve million people in the United States. FM is characterized by chronic widespread pain, fatigue, aching, joint stiffness, depression, cognitive dysfunction and non-restorative sleep. The mechanism of induction of muscle pain and inflammation is not yet clear. In FM there is an increase in reactivity of central neurons with increased sensitivity localized mainly in the CNS. Mast cells are involved in FM by releasing proinflammatory cytokines, chemokines, chemical mediators, and PGD2. TNF is a cytokine generated by MCs and its level is higher in FM. The inhibition of pro-inflammatory IL-1 family members and TNF by IL-37 in FM could have a therapeutic effect. Here, we report for the first time the relationship between MCs, inflammatory cytokines and the new anti-inflammatory cytokine IL-37 in FM.